Diagnostics & Research
The Diagnostics & Research industry has a total of 57 stocks, with a combined market cap of $587.31 billion, total revenue of $161.25 billion and a weighted average PE ratio of 50.64.
Market Cap
587.31B
Revenue
161.25B
Profits
11.6B
PE Ratio
50.64
Profit Margin
7.19%
Dividend Yield
0.26%
55 Stocks
No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
---|---|---|---|---|---|---|
1 | TMO | Thermo Fisher Scientific Inc. | 166.05B | -2.11% | 1,691,644 | 42.88B |
2 | DHR | Danaher Corporation | 135.75B | -1.67% | 2,113,298 | 23.88B |
3 | IDXX | IDEXX Laboratories, Inc. | 32.63B | -0.49% | 688,275 | 3.90B |
4 | A | Agilent Technologies, Inc. | 29.42B | -1.90% | 638,962 | 6.53B |
5 | IQV | IQVIA Holdings Inc. | 26.37B | -0.88% | 658,960 | 15.41B |
6 | MTD | Mettler-Toledo International Inc. | 21.69B | -3.89% | 159,731 | 3.87B |
7 | NTRA | Natera, Inc. | 20.42B | 1.74% | 509,685 | 1.70B |
8 | WAT | Waters Corporation | 19.26B | -2.87% | 277,043 | 2.96B |
9 | LH | Labcorp Holdings Inc. | 18.86B | -1.21% | 283,044 | 13.01B |
10 | DGX | Quest Diagnostics Incorporated | 18.61B | -0.17% | 617,359 | 9.87B |
11 | ILMN | Illumina, Inc. | 11.84B | -0.36% | 639,544 | 4.37B |
12 | ICLR | ICON Public Limited Company | 11.72B | -1.12% | 564,092 | 8.28B |
13 | RVTY | Revvity, Inc. | 11.50B | -1.94% | 745,852 | 2.76B |
14 | MEDP | Medpace Holdings, Inc. | 9.24B | -0.61% | 341,468 | 2.11B |
15 | QGEN | Qiagen N.V. | 8.99B | -1.72% | 1,750,068 | 1.98B |
16 | EXAS | Exact Sciences Corporation | 8.04B | -2.17% | 891,385 | 2.76B |
17 | GH | Guardant Health, Inc. | 5.64B | 1.20% | 1,339,379 | 739.02M |
18 | CRL | Charles River Laboratories International, Inc. | 5.19B | -0.96% | 1,547,921 | 4.05B |
19 | RDNT | RadNet, Inc. | 3.91B | -1.09% | 286,831 | 1.83B |
20 | SHC | Sotera Health Company | 2.96B | -1.55% | 619,182 | 1.10B |
21 | WGS | GeneDx Holdings Corp. | 2.79B | -1.48% | 340,445 | 305.45M |
22 | VCYT | Veracyte, Inc. | 2.45B | -2.08% | 417,786 | 445.76M |
23 | TWST | Twist Bioscience Corporation | 2.34B | -1.43% | 427,404 | 330.19M |
24 | NEO | NeoGenomics, Inc. | 1.22B | -2.06% | 1,099,298 | 660.57M |
25 | NEOG | Neogen Corporation | 1.08B | -8.06% | 4,801,076 | 906.00M |
26 | CDNA | CareDx, Inc | 1.06B | 0.95% | 213,827 | 333.79M |
27 | OPK | OPKO Health, Inc. | 967.03M | 1.41% | 1,278,552 | 713.14M |
28 | GRAL | GRAIL, Inc. | 868.57M | 3.12% | 770,987 | 125.60M |
29 | MYGN | Myriad Genetics, Inc. | 728.65M | -1.24% | 359,583 | 837.60M |
30 | CSTL | Castle Biosciences, Inc. | 588.82M | 3.82% | 188,331 | 332.07M |
31 | FLGT | Fulgent Genetics, Inc. | 582.74M | -0.37% | 107,607 | 283.47M |
32 | PSNL | Personalis, Inc. | 286.41M | 0.15% | 217,582 | 84.61M |
33 | STIM | Neuronetics, Inc. | 250.42M | -0.13% | 205,180 | 74.89M |
34 | ATLN | Atlantic International Corp. | 232.19M | 1.36% | 12,183 | 442.61M |
35 | ACRS | Aclaris Therapeutics, Inc. | 122.49M | -3.81% | 311,892 | 18.72M |
36 | BDSX | Biodesix, Inc. | 86.68M | -1.85% | 171,883 | 71.32M |
37 | OCX | OncoCyte Corporation | 85.80M | 5.45% | 23,122 | 1.88M |
38 | XGN | Exagen Inc. | 80.02M | -2.81% | 62,225 | 55.64M |
39 | MDXH | MDxHealth SA | 77.71M | 0.64% | 17,833 | 90.05M |
40 | FONR | FONAR Corporation | 77.52M | 1.45% | 6,535 | 101.57M |
41 | NOTV | Inotiv, Inc. | 60.12M | 14.52% | 1,075,524 | 475.11M |
42 | PRE | Prenetics Global Limited | 46.55M | 2.70% | 10,294 | 25.56M |
43 | BNR | Burning Rock Biotech Limited | 30.57M | 2.41% | 7,691 | 70.67M |
44 | ENZ | Enzo Biochem, Inc. | 17.58M | -3.90% | 431,413 | 29.09M |
45 | PRPH | ProPhase Labs, Inc. | 12.30M | -2.55% | 337,084 | 6.77M |
46 | MYNZ | Mainz Biomed N.V. | 10.24M | 0.01% | 83,399 | 893.99K |
47 | BIAF | bioAffinity Technologies, Inc. | 8.85M | -1.20% | 91,168 | 9.36M |
48 | PRPO | Precipio, Inc. | 8.26M | -2.83% | 10,521 | 18.53M |
49 | STRR | Star Equity Holdings, Inc. | 6.17M | -3.00% | 1,639 | 53.36M |
50 | CHEK | Check-Cap Ltd. | 4.16M | 8.88% | 4,204 | - |
51 | XWEL | XWELL, Inc. | 3.98M | -1.27% | 6,966 | 33.83M |
52 | AWH | Aspira Women's Health Inc. | 2.72M | -6.73% | 432,925 | 9.18M |
53 | NDRA | ENDRA Life Sciences Inc. | 1.78M | 1.93% | 29,379 | - |
54 | ISPC | iSpecimen Inc. | 1.19M | -2.37% | 25,378 | 9.29M |
55 | APDN | Applied DNA Sciences, Inc. | 916.13K | -9.40% | 994,682 | 3.74M |